Drug intelligence / Profile preview

glycyrrhizin

Development stage
Phase 4
Lead developer
Minophagen Pharmaceutical
Modality
Nucleic Acid-Directed Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral, Intravenous, Topical
01

Overview

Glycyrrhizin (also known as glycyrrhizic acid or glycyrrhizinic acid) is a triterpene saponin and the chief sweet-tasting constituent of licorice root (*Glycyrrhiza glabra*). It is 30 to 50 times sweeter than sucrose and is used as a natural sweetener, emulsifier, and gel-forming agent in foodstuffs, cosmetics, and dietary supplements. Pharmacologically, it has been developed primarily in Japan and China as a hepatoprotective drug for chronic hepatitis. Glycyrrhizin exhibits anti-inflammatory, antiviral, anti-ulcer, antioxidant, antiallergic, antihyperglycemic, anti-lipidemic, immunomodulatory and potential antitumor activities. Its mechanisms include inhibition of viral replication (including hepatitis C virus), suppression of TNF-alpha and caspase 3 activity (anti-inflammatory), inhibition of NF-kB translocation into nuclei (anti-inflammatory), conjugation of free radicals (antioxidant), modulation of T-cell function via JNK/ERK/PI3K-AKT pathways (immunomodulation), reversible inhibition of the enzyme 11-beta-hydroxysteroid dehydrogenase leading to increased mineralocorticoid activity in the kidney. After oral ingestion it is hydrolyzed by intestinal bacteria to its aglycone enoxolone (18β-glycyrrhetinic acid). Glycyrrhizin has also been investigated for use against viral infections such as herpes simplex virus and SARS-associated coronavirus[2][4][5][6].

Brand names
Glycyron
Other names
ammonium glycyrrhizinmono-ammonium glycyrrhizin
02

Targets

HMGB1 (High mobility group protein B1)CASP3 (Caspase-3)HSD11B2 (11β-HSD2)NF-κBSTAT3 (Signal Transducer and Activator of Transcription 3)JAK1 (Janus kinase 1)

Beyond the preview

Go deeper on glycyrrhizin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on glycyrrhizin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call